- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
I am currently working as a Consultant Clinical Oncologist at the Nottingham University Hospitals as Stereotactic Radiosurgery (SRS) and Brain Metastases MDT Lead Clinician. I also treat patients with Stereotactic Ablative Radiotherapy (SABR/SBRT) for Oligometastases, Hepatobilliary (HpB) tumours and breast cancer. I have set up the East Midlands Brain Metastases MDT and SRS Service.
I have a broad experience in the field of high advanced radiotherapy treatments. My main expertise is in the area of the Stereotactic Radiotherapy (SRS and SABR/SBRT), with a vast professional experience using Gammknife, Cyberknife, Magnetic Resonance Image Guided Radiotherapy (MRL) and Linac-based platforms to treat metastatic disease as well as primary tumours. I have treated with Stereotactic techniques more than 1000 patients since 2001.
I have been Head of Radiotherapy Department at Leicester University Hospitals for 3 years and Head of Radiotherapy and Radiosurgery at Ruber International Hospital (Madrid, Spain) for 2 years. I have been a Clinical Oncologist Consultant for more than 20 years.
I have been for several years Genesis Care UK SABR Clinical Advisor and SRS Clinical Lead, setting up the SRS Service at Oxford Genesis Care.
I am Honorary (Consultant) Assistant Professor at University of Nottingham.
I am member of multiple National and International Oncological Societies (ESTRO, ISRS, ESMO, RCR, SEOR…).
I am Editor of several International Oncological Journals.
I have published around 39 papers in International Medical Journals, books and meeting presentations.
I am Investigator in several Stereotactic Radiotherapy Trials (CORE, ABC-07, OligoRare, SARON, HALT, SPARC, SCALOP 2), some of them as Principal Investigator.
I have presented dozens of abstracts in Congresses, presentations in International meetings, and attended relevant Conferences.
I was awarded with the UK 1st Prize Macmillan Innovation Excellence Award 2019 for East Midlands Brain Metastases/SRS Service.
Areas of interest
Brain Stereotactic Radiosurgery (SRS) (metastases and primary tumours); Neuro Oncology: Stereotactic Ablative Radiosurgery (SABR) for Oligometastasis; Hepatobiliary cancers (pancreas and liver cancer); Breast Cancer; Cancer; Lung cancer; Lymph Node Tumours; Adrenal Tumours; Brain Metastasis; SABR for Lung Cancer;
Current NHS consultant posts held
Consultant Clinical Oncologist at the Nottingham University Hospitals as SRS and Brain Metastases MDT Lead Clinician.
Honorary (Consultant) Assistant Professor
University of Nottingham, School of Medicine.
Neuro oncology. HpB cancers. SBRT for oligometastasis.
SRS and SBRT Stereotactic Radiotherapy techniques.
Sport. Walking in nature.
UK 1st Prize Macmillan Innovation Excellence Award 2019 for East Midlands Brain Metastases/SRS Service.
(Additional) Languages spoken
- Spanish - Native or bilingual
More than 37 international papers published.
Reference number 7450672
Affiliations / memberships
European Society of Radiology and Oncology Member (ESTRO)
European Society of Medical Oncology (ESMO)
Royal College of Radiologist Membership (RCR)
Radiation Oncology Spanish Society Member (SEOR)
- The Park Cancer CentreSherwood Lodge...
- 13:30 - 17:30
- 0115 966 2254
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (5-50)
Stereotactic radiotherapy (SRT) using GammaKnife or similar SRT technology - (5-50)
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (5-50)
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
- Show All (6 )...